Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans trained to discriminate among d-amphetamine, meta- chlorophenylpiperazine and placebo

Drug and Alcohol Dependence

Volumn 81, Issue 1, 2006, Pages 27-36

  Johanson, Chris Ellyn ^a   Kilbey, Marlyne ^a   Gatchalian, Kristin ^b   Tancer, Manuel ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

3,4 Methylenedioxymethamphetamine; d Amphetamine; Drug discrimination; Humans; meta Chlorophenylpiperazine

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; DEXAMPHETAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; PLACEBO; SEROTONIN AGONIST;

ADULT; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; PRIORITY JOURNAL; TRAINING;

ADULT; ALCOHOLISM; AMPHETAMINE-RELATED DISORDERS; AROUSAL; DEXTROAMPHETAMINE; DISCRIMINATION LEARNING; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HALLUCINOGENS; HUMANS; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PIPERAZINES; SEROTONIN AGENTS;

ANIMALIA;

EID: 27944454723     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2005.05.003     Document Type: Article

References (28)

1. L.E. Baker, J. Broadbent, E.K. Michael, P.K. Matthews, C.A. Metosh, R.B. Saunders, W.B. West, and J.B. Appel Assessment of the discriminative stimulus effects of the optical isomers of ecstasy (3,4-methylenedioxymethamphetamine; MDMA) Behav. Pharmacol. 6 1995 263 275
2. L.E. Baker, and M.M. Taylor Assessment of the MDA and MDMA optical isomers in a stimulant-hallucinogen discrimination Pharmacol. Biochem. Behav. 57 1997 737 748
3. P.M. Beardsley, R.L. Balster, and L.S. Harris Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus monkeys Drug Alcohol Depend. 18 1986 149 157
4. 2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP) Eur. J. Pharmacol. 257 1994 27 38
5. J. Cami, M. Farre, M. Mas, P.N. Roset, S. Poudevida, A. Mas, L. San, and R. de la Torre Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects J. Clin. Psychopharmacol. 20 2000 455 466
6. J.C. Cole, and H.R. Sumnall The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA) Neurosci. Biobehav. Rev. 27 2003 199 217
7. S.M. Evans, and C.E. Johanson Discriminative stimulus properties of (+/-)-3,4-methylenedioxymethamphetamine and (+/-)-3, 4-methylenedioxyamphetamine in pigeons Drug Alcohol Depend. 18 1986 159 164
8. S.M. Evans, J.P. Zacny, and C.E. Johanson Three-choice discrimination among (+)-amphetamine, fenfluramine and saline in pigeons Pharmacol. Biochem. Behav. 35 1990 971 980
9. W.E. Fantegrossi, T. Ullrich, K.C. Rice, J.H. Woods, and G. Winger 3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement Psychopharmacology (Berl) 161 2002 356 364
10. First, M.B., Spitzer, R.L., Gibbon, M., Williams, J.B.W., 1996. Structured Clinical Interview of DSM-IV Axis I Disorders-Patient Edition (SCID I/P, Version 2). Biometrics Research Department, NY State Psychiatric Institute, New York.
11. M. Gatch Discriminative stimulus effects of m-chlorophenylpiperazine as a model of the role of serotonin receptors in anxiety Life Sci. 73 2003 1347 1367
12. 2C receptor mode of action Psychopharmacology 137 1998 292 302
13. A.K. Goodwin, and L.E. Baker A three-choice discrimination procedure dissociates the discriminative stimulus effects of d-amphetamine and (+/-)-MDMA in rats Exp. Clin. Psychopharmacol. 8 2000 415 423
14. A.K. Goodwin, D.M. Pynnonen, and L.E. Baker Serotonergic-dopaminergic mediation of MDMA's discriminative stimulus effects in a three-choice discrimination Pharmacol. Biochem. Behav. 74 2003 987 995
15. A.R. Green, A.O. Mechan, J.M. Elliott, E. O'Shea, and M.I. Colado The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") Pharmacol. Rev. 55 2003 463 508
16. C.S. Grob, R.E. Poland, L. Chang, and T. Ernst Psychobiologic effects of 3,4-methylenedioxymethamphetamine in humans: methodological considerations and preliminary observations Behav. Brain Res. 73 1996 103 107
17. R.S. Kahn, and S. Wetzler m-Chlorophenylpiperazine as a probe of serotonin function Biol. Psychiatry 30 1991 1139 1166
18. J.B. Kamien, C.E. Johanson, C.R. Schuster, and W.L. Woolverton The effects of (+/-)-methylenedioxymethamphetamine and (+/-)- methylenedioxyamphetamine in monkeys trained to discriminate (+)-amphetamine from saline Drug Alcohol Depend. 18 1986 139 147
19. R.J. Lamb, and R.R. Griffiths Self-injection of d,1-3, 4-methylenedioxymethamphetamine (MDMA) in the baboon Psychopharmacology 91 1987 268 272
20. W.R. Martin, J.W. Sloan, J.D. Sapira, and D.R. Jasinski Physiologic, subjective and behavioral effects of amphetamine, ephedrine, phenmetrazine, and methylphenidate in man Clin. Pharmacol. Ther. 12 1971 245 258
21. McNair, D.M., Lorr, M., Droppleman, L.F., 1971. Manual for the Profile of Mood States. Educational and Industrial Testing Service, San Diego.
22. R. Oberlender, and D.E. Nichols Drug discrimination studies with MDMA and amphetamine Psychopharmacology 95 1988 71 76
23. M.D. Schechter Discriminative profile of MDMA Pharmacol. Biochem. Behav. 24 1986 1533 1537
24. I. Stolerman Drug discrimination. Methods in behavioral pharmcology F. Van Haaren Methods in Behavioral Pharmcology 1993 Elsevier Science Amsterdam 217 224
25. R.J. Strassman, C.R. Qualls, E.H. Uhlenhuth, and R.K. Kellner Dose response study of N,N-dimethyltryptamine in humans Arch. Gen. Psychiatry 51 1994 98 108
26. M. Tancer, and C.E. Johanson Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP Drug Alcohol Depend. 72 2003 33 44
27. M.E. Tancer, and C.E. Johanson The subjective effects of MDMA and mCPP in moderate MDMA users Drug Alcohol Depend. 65 2001 97 101
28. F.X. Vollenweider, A. Gamma, M. Liechti, and T. Huber Psychological and cardiovascular effects and short-term sequelae of MDMA ("ecstasy") in MDMA-naive healthy volunteers Neuropsychopharmacology 19 1998 241 251